A Clinical Study to Examine the Drug-drug Interactions Between ACT-541468 and Citalopram in Healthy Male and Female Subjects

NCT03907215 PHASE1 COMPLETED

A clinical study to examine the drug-drug interactions between ACT-541468 and citalopram in healthy male and female subjects

Details

Lead sponsor	Idorsia Pharmaceuticals Ltd.
Phase	PHASE1
Status	COMPLETED
Enrolment	24
Start date	Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Jun 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Healthy

Interventions

• ACT541468
• ACT541468 placebo
• Citalopram

Countries

Germany